Screener
IXJ vs IDNA
iShares Global Healthcare ETF vs iShares Genomics Immunology and Healthcare ETF
Key differences
- IXJ costs 0.07% less per year.
- IXJ is significantly larger than IDNA — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IDNA has delivered higher annualized returns.
- IXJ has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IXJ | IDNA | |
|---|---|---|
| Annual cost (TER) | 0.40% | 0.47% |
| Fund size (AUM) | $3.6B | $160M |
| Since | 2001 | 2019 |
| Dividend yield | 1.46% | 1.05% |
| Asset class | equity | equity |
| Region | — | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +13.6% | +49.2% |
| CAGR 3Y | +5.1% | +8.0% |
| CAGR 5Y | +4.6% | -7.5% |
| Sharpe 3Y | 0.17 | 0.29 |
| Volatility 1Y | 14.45% | 24.43% |
| Max drawdown | -27.35% | -68.26% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IXJ and IDNA
Explore further